Section 3: Vision

3.1 Vision
KPACORA LAB INC is committed in discovering and delivering high-value anti-aging
formulations. It as a ne anti-aging that ill ma!e a real difference in im"ortant areas of
healthcare# hich a$le to "revent and treat the aging related diseases. %he com"an& is
committed to reali'e the ne ideas that ill hel" to o"timi'e human aging "rocesses in a
health& manner.
3.2 Mission
It is "ossi$le to sum u" KPACORA LAB INC $elieves in and strives for ()oung and
*ealth& through a ne technolog&. %his recogni'es that in a com"etitive and fast-changing
orld# the values of "roducts and com"anies are constantl& changing. In order for things to
have real value to the customer# it has to $e su"erior to an& other offering and therefore $etter
than others. In toda&+s glo$al mar!ets# real customer value can onl& $e created $&
KPACORA LAB INC hich constantl& finding a&s of doing ne things ell.
3.3 Objectives & Plans
,. Co-mar!eting efforts and strengthening the "i"eline through a""ro"riate e-ternal
targeted ac.uisition# licensing and "artnershi" o""ortunities.
/. %o im"rove continuall& our "roduct and services to meet customers needs#
alloing us to "ros"er as a $usiness and to "rovide a reasona$le return for our
stoc!holders.
0. 1te" u" investments in develo"ment and "re-mar!eting to su""ort late stage
"i"eline o""ortunities and to $uild a strong $rand.
2. Brand3 Promote 4O56N%A76 as the ne first choice of anti-aging formulations.
Among anti-aging formulations differentiating is the ne technolog& in
delivering the anti-aging formulations through a smart microchi" drug "um".
8. 1ales3
KPACORA LAB INC | Pharmaceutical
Technologies
9a-imi'e sales groth $& releasing the full "otential of our mar!eted $rands
throughout their lifec&cle.
7roing our "osition in e-isting mar!ets.
6-"anding our "resence in !e& emerging mar!ets.
5igorousl& defending our legitimate intellectual "ro"ert& rights.
6-ceed com"etitors+ coverage and fre.uenc&.
:. Product3
;eliver a "ortfolio of differentiated medicines that meet "atient needs $&
successfull& delivering the ne-t ave of "roducts in develo"ment.
Rigorous management of our "ortfolio of "roducts in develo"ment# to mitigate
ris!s associated ith ne innovative "roducts
<urther im"roving the "roductivit& and efficienc& of our drug discover& and
develo"ment.
1trengthening the "i"eline through a""ro"riate e-ternal targeted ac.uisition#
licensing and "artnershi" o""ortunities.
=. Com"an&3
Peo"le 9anagement3 increase com"an& a$ilit& focusing on field force
efficienc& and efficient "roduct management.
Leading and develo"ing "eo"le to im"rove $usiness com"etence in all
functions.
>. 7oals3
Long-term3 %o $ecome an international cor"oration.
9edium3 %o im"rove .ualit& and servicea$ilit&.
KPACORA LAB INC | Pharmaceutical
Technologies
1hort-term3 Acce"ted "rice ith fair .ualit&.
%he goal of anti-aging thera"& is to "rolong a health& human e-istence. %he
essence of anti-ageing medicine em$races health and vitalit& to "romote
longevit& and "revent the diseases of ageing. %hus# the aim of anti-aging
medicine is not onl& to slo don the aging "rocess# $ut also to !ee" the $od&
functioning at its o"timum level.
3.4 Market Research
%oda&s anti-aging mar!et is e-"anding to incor"orate diverse consumer concerns. 1"ending
on anti-aging "roducts is e-"ected to reach ?/@,.@ $illion $& /A,8# according to a 7lo$al
Industr& Anal&sts re"ort. Bith this level of "roCected groth# its no sur"rise that $eaut& and
"ersonal care $rands# manufacturers and su""liers around the orld are closel& monitoring
consumer trends for a "iece of the mar!et. <urthermore# the "ro"ortion of the orlds
"o"ulation aged :A or over currentl& stands at ,AD $ut this figure is e-"ected to more than
dou$le to //D $& /A8A. One of the Borld *ealth Organi'ations (ten glo$al health targets for
the /,st centur& is to achieve an increase in life e-"ectanc& and in the .ualit& of life for all.
It is "redicted that $& the &ear /A/@# advancements anti-aging research ill $e enriched that
im"rove and e-tend the human life s"an. In this manner# anti-aging medicine is antici"ated to
have a "rofound and "ermanent im"act on the future of "reventative health care.
A clinical s"ecialt& founded on the a""lication of advanced scientific and medical
technologies for anti-aging medicine aims not to merel& "rolong the total &ears of an
individuals life# $ut to ensure that those &ears are enCo&ed in a "roductive and vital fashion.
%he e-"onential groth in the "o"ularit& of anti-aging medicine is largel& a result of the
glo$al demogra"hics shift toards a selling aging "o"ulation. %he Enited Nations o$serves
that3 F%he orld is in the midst of a uni.ue and irreversi$le "rocess of demogra"hic transition
KPACORA LAB INC | Pharmaceutical
Technologies
that ill result in older "o"ulations ever&here. As fertilit& rates decline# the "ro"ortion of
"ersons aged :A and over is e-"ected to dou$le $eteen /AA= and /A8A# and their actual
num$er ill more than tri"le# reaching / $illion $& /A8A. In most countries# the num$er of
those over >A is li!el& to .uadru"le to nearl& 2AA million $& then.G %hrough the forecast
&ears /A,0 to /A,># the mar!et ill e-"erience Com"ound Annual 7roth Rate HCA7RI of
8./D# to reach ?/>2.: $illion. In /A,0# the service mar!et ill li!el& end ith sales reaching
?2A.: $illion and gro to nearl& ?:,./ $illion $& /A,># a CA7R of >.:D# re"resenting a
faster groing segment of the anti-aging mar!et.
Bhile the orlds total "o"ulation gros at an annual rate of ,.=D# the segment over
age :8 increases $& /.8D "er &ear. ;evelo"ed nations# than!s in large "art to their ado"tion
of diagnostic techni.ues affording screening and earl& detection of disease# have e-"erienced
a "rofound transformation of their demogra"hics# thus nearl& /AD of the develo"ed orld is
age :A a$ove. In the ne-t /A to 0A &ears# %he Borld *ealth Organi'ation "roCects that elderl&
"o"ulations in develo"ed countries ill increase $& 0A to ,2AD# and in develo"ing countries
this $rac!et ill gro $& /AA to 2AAD. Bith a orldide life e-"ectanc& no standing at
=>.8@ &ears Heighted averageI# and a "roCected orld "o"ulation e-ceeding @ $illion $& the
&ear /A8A# the field of anti-aging medicine is itnessing un"recedented groth and
acce"tance.
%he first five-&ear "lan is to $uild $rand lo&alt& in customers. %his is a com"rehensive
o$Cective of KPACORA LAB INC. It is necessar& for KPACORA LAB INC to found a
$rand and then $uild $rand lo&alt&. %here are lots of ste"s for KPACORA LAB INC to $e
gone through# since KPACORA LAB INC should $uild a ne $rand# im"rove the services#
"rovide good-.ualit& "roducts# advertising and mar!et "romotion. KPACORA LAB INC
also needs to let customers !no the $rand first# and then ma!e the customers !no
KPACORA LAB INC "roviding uni.ue services and high .ualit& "roducts. %hrough the
em"irical research# mar!eting strateg& "lan suggestion has $een created. It ill hel"
KPACORA LAB INC to achieve the mar!et o$Cectives. It is necessar& to $uild a ne
famous $rand. KPACORA LAB INC also needs to let the customers !no the $rand after it
"roducesJ the tr&out of the "roduct is a good a&. Ne $rand ill ta!e a long time to $ecome
famous. %he suggestions from customers are im"ortant for the ne $rand# thus the after-sale
services should $e im"roved. %hrough the anal&sis of after-sale services# KPACORA LAB
KPACORA LAB INC | Pharmaceutical
Technologies
INC can gain different customers demand# and do some changes a$out the "roduct to satisf&
a variet& of customer demands. A drug formulations de"artment "la&s an im"ortant role. %he
drug formulation de"artment is to e-"lore ne medicine for ne customers. <or the service
"art# the service de"artment should $e im"roved. %he service de"artment should $e "a&ing
attention to the after-sale services. %he after-sale services need to accord the customers need
and give it to drug formulations. No# "eo"le have an increasing num$er of demands on their
health.
1econd# after the ne $rand as created# the KPACORA LAB INC ill attem"t to
im"rove the mar!eting "romotion and $rand lo&alt& to ma!e "eo"le !no the ne $rand.
Advertising of the ne $rand ill $e increased "ut into mar!ets through the nes"a"ers# %5
or the Internet under the KPACORA LAB INCs a$ilit&. %he KPACORA LAB INC also in
the direction of holds some "romotion activities to attract customers# in addition to the
advertisement.
%hird# KPACORA LAB INC can e-"lore medicinal commodities ith medicine
inside. %he "roduct ith different anti-aging medicine inside can attract the different target
grou". KPACORA LAB INC also ishes to $uild $rand image# $ecause not so man&
customers !no the KPACORA LAB INC+s "roducts. Increasing s"ending on advertising is
ver& necessar& for the com"an&.
<inall&# the Internet is a good medium for the KPACORA LAB INC develo"ment.
An increasing num$er of "eo"le use the Internet to get information such as nes# and $rands.
Almost all countries# "eo"le use <ace$oo! and %itter. %he KPACORA LAB INC is
striving to create a "rofessional e$ site and ma!e "eo"le accessi$le at the e$site# in order
to ma!e "eo"le !no the KPACORA LAB INC and our "roduct.
KPACORA LAB INC | Pharmaceutical
Technologies
Section 4: Management & Organiation
4.1 Management !eam
%he core management team of KPACORA LAB INC includes several e-ecutives ith
successful $ac!grounds in the "harmaceutical industr& and e-"erience ith start-u"
o"erations. %he& are the "eo"le ho have an e-"erience in the healthcare "rovider and
"harmaceutical "roduct develo"ment3
Ahmad 9ui''# is KPACORA LAB INCs President and "hie# $%ec&tive O##icer.
9r. 9ui'' received his "harmac& degree from Eniversit& of 9ala&a ith high honours. *e
has com"leted a felloshi" in <unctional 9edicine and Anti-Aging affiliated ith the
American Academ& of Anti-Aging 9edicine and has $een $oard certified $& the Board of
Anti-Aging *ealth Practitioners as a *ealth Practitioner ;i"lomat. <urthermore# 9r. 9ui''s
career is founded on e-tensive "harmaceutical sales and mar!eting e-"erience. As a
conse.uence# he also "lans our advertising# mar!eting cam"aigns# educational seminars and
s"ea!ing o""ortunities for our "harmacists.
KPACORA LAB INC | Pharmaceutical
Technologies
9uhammad 1anim# is KPACORA LAB INCs "hie# 'inancial O##icer. 9r. 1anim
holds a B.1. in <inance and Organi'ational 9anagement from the Eniversit& of 9ala&a and
an International 9.B.A. from the Eniversit& British Colum$ia 1chool of Business. 9r. 1anim
ill $e res"onsi$le for the KPACORA LAB INC+s accounting# cor"orate finance# financial
"lanning# investor relations# and administration functions.
%ho Li )an# is KPACORA LAB INCs "hie# (n#ormation O##icer. 9s. Li )an
earned her degree in "harmac& from Eniversit& of 9ala&a. *er ca"a$ilit& is having strong
inter"ersonal communication and relational s!ills# good organi'ational and "roCect
management s!ills. 1he also led several research and develo"ment "rograms for KPACORA
LAB INC as she had e-tensive understandings in "ro"osing $udgets for "roducts and
"roCects# "urchases and u"grades e.ui"ment.
Pauline %an Kinli# KPACORA LAB INCs "hie# O)erational O##icer. 9s. Pauline
earned her degree in "harmac& from Eniversit& of 9ala&a and his 9asters in "harmaceutics
from the Eniversit& of 9ichigan. 1he is an e-"ert in transdermal drug deliver& and sustained
release dosage forms. 9s. Paulines scientific training and understanding of the
"h&siochemical "ro"erties of drugs and e-ci"ients "rovide KPACORA LAB INC ith a
uni.ue e-"ertise $e&ond hat is t&"icall& found in com"ounding "harmacies.
4.2 O)erations
KPACORA LAB INC o"erates from a facilit& located at 1enai *igh %ech Par!# 4ohor.
Products are formulated at this location and all manufacture and assem$l& as "erforms here.
Lualit& control and distri$ution to customers are handled $& the 1enai *igh %ech Par!
facilit&.
KPACORA LAB INC | Pharmaceutical
Technologies
4.3 Organiational
*+P,"OR, -,. (/"+s Organiational "hart
KPACORA LAB INC | Pharmaceutical
Technologies
KPACORA LAB INC | Pharmaceutical
Technologies